Geneva, Switzerland

Limin Shang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Limin Shang: Innovator in Antibody Therapeutics

Introduction

Limin Shang is a prominent inventor based in Geneva, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapeutics. With a total of four patents to his name, Shang's work focuses on addressing critical medical challenges.

Latest Patents

Shang's latest patents include groundbreaking inventions such as bispecific antibodies targeting CD47 and PD-L1. This disclosure provides novel bispecific antibodies that specifically bind to CD47 and Programmed Death-Ligand 1 (PD-L1). The invention further relates to methods of making these bispecific antibodies and nucleic acids encoding the antibodies. Additionally, it outlines therapeutic methods for using the bispecific antibodies in treating conditions associated with malignant cells expressing CD47 and/or PD-L1. Another significant patent involves anti-Toll-like Receptor 4 (TLR4) antibodies and methods of use thereof. This invention relates to anti-TLR4 antagonists, including antibodies that specifically bind to TLR-4. It also details methods for using these antagonists as therapeutics to inhibit or delay the progression of Graft-versus-Host disease (GvHD) and improve survival rates in affected subjects.

Career Highlights

Limin Shang is currently associated with Novimmune SA, a company known for its focus on developing innovative antibody-based therapies. His work at Novimmune has positioned him as a key player in the biotechnology sector, contributing to advancements in therapeutic solutions.

Collaborations

Shang collaborates with notable colleagues, including Emmanuel Monnet and Greg Elson. These partnerships enhance the research and development efforts within the company, fostering innovation in antibody therapeutics.

Conclusion

Limin Shang's contributions to the field of biotechnology, particularly through his innovative patents, highlight his role as a leading inventor in antibody therapeutics. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…